IFNA1 and cancer: Across a range of cancers, a series of consensus TAM subtypes have been identified by multiple groups: interferon‐primed TAMs (IFN‐TAMs), immune regulatory TAMs (Reg‐TAMs), inflammatory cytokine‐enriched TAMs (Inflam‐TAMs), lipid‐associated TAMs (LA‐TAMs), pro‐angiogenic TAMs (Angio‐TAMs), RTM‐like TAMs (RTM‐TAMs), and proliferating TAMs (Prolif‐TAMs) [22, 41].